The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of stereotactic ablative radiotherapy for extra-cranial oligo-metastatic renal cell cancer.
 
Yuanyuan Zhang
No Relationships to Disclose
 
Jonathan Schoenhals
No Relationships to Disclose
 
Alana Christie
No Relationships to Disclose
 
Chiachien Wang
No Relationships to Disclose
 
Osama Mohamad
No Relationships to Disclose
 
Nirmish Singla
No Relationships to Disclose
 
Neil Desai
No Relationships to Disclose
 
Hak Choy
No Relationships to Disclose
 
Kevin Dale Courtney
Stock and Other Ownership Interests - Regeneron (I)
Consulting or Advisory Role - Janssen
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma; Astellas Pharma (Inst); Astellas Pharma (Inst); Clovis Oncology (Inst); Corvus Pharmaceuticals (Inst); Lilly (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Peloton Therapeutics (Inst); Proacta (Inst); PSMA Development Company (Inst); Stemline Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - My spouse receives patent royalties from Athena Diagnostics, Inc. (I)
 
Aditya Bagrodia
No Relationships to Disclose
 
Vitaly Margulis
Honoraria - Astellas Pharma; Bayer; ferring; Genomic Health; Johnson & Johnson; MDxHealth
Speakers' Bureau - Astellas Pharma; Bayer; Ferring; Genomic Health; Johnson & Johnson; MDxHealth
 
I. Alex Bowman
No Relationships to Disclose
 
Robert D. Timmerman
Research Funding - Accuray (Inst); Elekta (Inst); Varian Medical Systems (Inst)
 
James Brugarolas
Consulting or Advisory Role - Nektar
Research Funding - Genentech/Roche
Patents, Royalties, Other Intellectual Property - Patent of HIF-2 biomarker (Inst)
Other Relationship - Nektar
 
Raquibul Hannan
No Relationships to Disclose